Physician profile
Herman Bagga
NPI 1427384841
$6,354.12
in general payments reported to CMS, 2019-2025
36 companies · $1,679 in 2025
The $1,679 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2021: $243 · 2022: $360 · 2023: $1,915 · 2024: $1,833 · 2025: $1,679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,426.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,118.26 | 2023-2025 | Titan, Porges Coloplast, Altis |
| Teleflex LLC | $992.19 | 2023-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $872.20 | 2019-2025 | Ams 700, Ams Ambicor, Spaceoar Vue System - 10ml |
| Medtronic, INC. | $675.62 | 2024-2025 | Interstim |
| Astellas Pharma US INC | $466.83 | 2019-2024 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $272.31 | 2023-2025 | Orgovyx, Gemtesa |
| Endo Pharmaceuticals INC. | $215.11 | 2023-2024 | Xiaflex, Aveed |
| Endo USA, INC. | $173.46 | 2024-2025 | Xiaflex, Aveed |
| Pfizer INC. | $173.20 | 2019-2025 | |
| Procept Biorobotics Corporation | $152.88 | 2023-2025 | Aquabeam Robotic System |
| Verity Pharmaceuticals INC. | $124.16 | 2025 | Trelstar, Tlando |
| Bayer Healthcare Pharmaceuticals INC. | $111.94 | 2023-2025 | |
| Ferring Pharmaceuticals INC. | $104.21 | 2024-2025 | Adstiladrin |
| Edap Technomed INC | $100.00 | 2023 | |
| Merck Sharp & Dohme LLC | $90.09 | 2024-2025 | Keytruda, Welireg |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $87.47 | 2022-2024 | |
| Laborie Medical Technologies Corp. | $82.50 | 2023-2025 | Optilume Urethral Drug Coated Balloon |
| Antares Pharma, INC. | $79.07 | 2023-2024 | Xyosted, Tlando, Nocdurna |
| Janssen Biotech, INC. | $61.87 | 2024-2025 | Erleada, Akeega |
| Tolmar, INC. | $47.61 | 2023-2025 | Rubraca, Jatenzo |
| Olympus America INC. | $31.72 | 2024-2025 | Itind System |
| Sun Pharmaceutical Industries INC. | $30.31 | 2024 | |
| Tempus Ai, INC | $28.58 | 2025 | Xt Cdx |
| Dendreon Pharmaceuticals LLC | $27.97 | 2024 | Provenge |
| Innovation Technologies INC | $27.13 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $25.53 | 2024 | Exparel, Iovera |
| Axonics, INC. | $24.54 | 2024 | Bulkamid |
| C. R. Bard, INC. & Subsidiaries | $22.32 | 2025 | Bard Urinary Drainage Bag |
| Pharmaand Gmbh | $22.04 | 2025 | Rubraca |
| Novartis Pharmaceuticals Corporation | $19.82 | 2025 | |
| Myriad Genetic Laboratories, INC. | $19.76 | 2023 | Prolaris |
| Blue Earth Diagnostics | $19.45 | 2023 | |
| Cycle Pharmaceuticals INC | $17.09 | 2025 | Venxxiva |
| Kowa Pharmaceuticals America, INC. | $16.62 | 2023 | Seglentis |
| Davol INC. | $14.86 | 2023 | Arista Ah Flexitip |
| Ambu INC. | $5.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herman Bagga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.